Exor NV , the investment arm of Italy's Agnelli family, has increased its stake in health technology company Philips to 18.7% ...

Koninklijke Philips tackles challenges in China while focusing on AI and cost-cutting. Find out why PHG stock is a buy with ...

Relating to its recall of sleep apnea equipment in the United States, Philips recently concluded a $1.1 billion personal injury settlement. Payments for settlement start in the first half of 2025.

1112 ET – Philips’s cautious outlook for this ... as the unit is recovering from its Respironics sleep apnea machines recall. Shares are down 12% at 23.81 euros.(helena.smolak@wsj.com) ...

Philips took a EUR 1.3 billion goodwill-impairment charge based on a consent decree proposed by the Food and Drug Administration for the settlement of the sleep apnea product recall and changes in ...

In our Sleep sector, an estimated 80 million individuals are suffering from Sleep apnea and remain undiagnosed ... we are accelerating our Vent exchange with the Philips program, but we are ...

Philips Respironics in connection with the 2021 recall of millions of CPAP sleep apnea devices and our nearly decade-long representation of Sempra Energy and SoCalGas following the 2015 Aliso ...

(helena.smolak@wsj.com) 0732 ET – Royal Philips’s business is on a better footing and can match sector growth as issues related to the recall of its Respironics sleep apnea machines are fairly ...

Philips ended 2024 deep in the red, suffering a loss of 698 million euros, the health tech company announced on Wednesday. It attributed the loss mainly to a 1.1 billion dollar settlement made in ...